Diagnostic approaches to Alzheimer's disease (Q33971355)

30 July 2017

1 reference

title

Diagnostic approaches to Alzheimer's disease (English)

1 reference

30 July 2017

0 references

M A Boss

1

1 reference

PubMed ID

10899443

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Biochimica et Biophysica Acta

30 July 2017

1 reference

30 July 2017

1502

1 reference

30 July 2017

1

1 reference

30 July 2017

188-200

1 reference

Attitudes of older adults' on being told the diagnosis of Alzheimer's disease

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Alzheimer's treatments that work now

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Guidelines on drug treatments for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

The development of biological markers for the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

A potential noninvasive neurobiological test for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Drop the Alzheimer's drop test

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Role of genetics in tests of genotype, status, and disease progression in early-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900044-2

7 January 2021

10.1016/S0925-4439(00)00044-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10899443